These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30730653)

  • 1. Progestogens and prevention of preterm birth in women at risk.
    Prescrire Int; 2016 Jul; 25(173):185-188. PubMed ID: 30730653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
    Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials.
    EPPPIC Group
    Lancet; 2021 Mar; 397(10280):1183-1194. PubMed ID: 33773630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in singleton gestations: a systematic review and meta-analysis.
    Boelig RC; Locci M; Saccone G; Gragnano E; Berghella V
    Am J Obstet Gynecol MFM; 2022 Sep; 4(5):100658. PubMed ID: 35562009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of progestatives for the prevention of spontaneous preterm birth].
    Azria E
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1280-1298. PubMed ID: 27776845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestogens in singleton gestations with preterm prelabor rupture of membranes: a systematic review and metaanalysis of randomized controlled trials.
    Quist-Nelson J; Parker P; Mokhtari N; Di Sarno R; Saccone G; Berghella V
    Am J Obstet Gynecol; 2018 Oct; 219(4):346-355.e2. PubMed ID: 29614278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal administration of progesterone for preventing preterm birth.
    Dodd JM; Flenady V; Cincotta R; Crowther CA
    Cochrane Database Syst Rev; 2006 Jan; (1):CD004947. PubMed ID: 16437505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progesterone and preterm birth.
    Norman JE
    Int J Gynaecol Obstet; 2020 Jul; 150(1):24-30. PubMed ID: 32524598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
    van Zijl MD; Koullali B; Naaktgeboren CA; Schuit E; Bekedam DJ; Moll E; Oudijk MA; van Baal WM; de Boer MA; Visser H; van Drongelen J; van de Made FW; Vollebregt KC; Muller MA; Bekker MN; Brons JTJ; Sueters M; Langenveld J; Franssen MT; Schuitemaker NW; van Beek E; Scheepers HCJ; de Boer K; Tepe EM; Huisjes AJM; Hooker AB; Verheijen ECJ; Papatsonis DN; Mol BWJ; Kazemier BM; Pajkrt E
    BMC Pregnancy Childbirth; 2017 Sep; 17(1):284. PubMed ID: 28870155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of progestogens in women with preterm premature rupture of membranes.
    Di Sarno R; Raffone A; Saccone G
    Minerva Ginecol; 2019 Apr; 71(2):121-124. PubMed ID: 30318880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral progesterone for the prevention of recurrent preterm birth: systematic review and metaanalysis.
    Boelig RC; Della Corte L; Ashoush S; McKenna D; Saccone G; Rajaram S; Berghella V
    Am J Obstet Gynecol MFM; 2019 Mar; 1(1):50-62. PubMed ID: 31172132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progesterone for Prevention of Preterm Birth--Evidence-based Indications].
    Kuon RJ; Abele H; Berger R; Garnier Y; Maul H; Schleußner E; Rath W;
    Z Geburtshilfe Neonatol; 2015 Jun; 219(3):125-35. PubMed ID: 26114408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
    O'Brien JM; Adair CD; Lewis DF; Hall DR; Defranco EA; Fusey S; Soma-Pillay P; Porter K; How H; Schackis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
    Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
    Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies.
    Rode L; Langhoff-Roos J; Andersson C; Dinesen J; Hammerum MS; Mohapeloa H; Tabor A
    Acta Obstet Gynecol Scand; 2009; 88(11):1180-9. PubMed ID: 19900136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestogens for the prevention of preterm birth and risk of developing gestational diabetes mellitus: a meta-analysis.
    Pergialiotis V; Bellos I; Hatziagelaki E; Antsaklis A; Loutradis D; Daskalakis G
    Am J Obstet Gynecol; 2019 Nov; 221(5):429-436.e5. PubMed ID: 31132340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity.
    Thinkhamrop J; Hofmeyr GJ; Adetoro O; Lumbiganon P; Ota E
    Cochrane Database Syst Rev; 2015 Jan; 1():CD002250. PubMed ID: 25621770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.